⌘K

Login Start Free

Home/Filings/4/0001209191-22-049205

4//SEC Filing

Edlin Richard A. 4

Accession 0001209191-22-049205

CIK 0000827871other

View on SEC.gov Company Profile

Filed

Sep 7, 8:00 PM ET

Accepted

Sep 8, 5:08 PM ET

Size

4.6 KB

Accession

0001209191-22-049205

Insider Transaction Report

Form 4

Period: 2022-09-06

EAGLE PHARMACEUTICALS, INC.EGRX

Edlin Richard A.

Director

Transactions

Sale
Common Stock
2022-09-06$30.99/sh−6,800$210,732→ 22,600 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

EAGLE PHARMACEUTICALS, INC.

CIK 0000827871

Entity typeother

Related Parties

1

filerCIK 0001699676

Filing Metadata

Form type: 4
Filed: Sep 7, 8:00 PM ET
Accepted: Sep 8, 5:08 PM ET
Size: 4.6 KB

View on SEC.gov